003120 — Ilsung IS Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual income statement for Ilsung IS Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	42,090	61,248	78,053	69,018	64,292
Cost of Revenue
Gross Profit	16,135	27,935	36,086	27,049	27,882
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	43,887	59,910	86,046	72,264	70,452
Operating Profit	-1,797	1,338	-7,993	-3,246	-6,161
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-1,523	142,296	-21,345	11,163	2,828
Provision for Income Taxes
Net Income After Taxes	-1,368	108,669	-20,941	13,094	1,166
Net Income Before Extraordinary Items
Net Income	-1,368	108,669	-20,941	13,094	1,166
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-1,368	108,669	-20,941	13,094	1,166
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-179	14,532	-2,995	1,322	171
Dividends per Share